Oragenics Inc. (OGEN) Financials
OGEN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 7.9 million | 1.4 million |
2023-06-30 | 8.5 million | 1.2 million |
2023-03-31 | 14.8 million | 1.7 million |
2022-12-31 | 14.8 million | 1.7 million |
OGEN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -1.5 million | 402925 |
2023-06-30 | -2.6 million | 63628 |
2023-03-31 | -2.4 million | -95577 |
2022-12-31 | -2.4 million | -95577 |
OGEN Net Income
No data available :(
OGEN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 5.8 million | - | 24337 |
2023-06-30 | 6.5 million | - | 255994 |
2023-03-31 | 11.4 million | - | 306650 |
2022-12-31 | - | - | 356886 |
OGEN Shares Outstanding
OGEN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 769350 | 1.3 million | - |
2023-06-30 | - | 2.0 million | 1.1 million | - |
2023-03-31 | 3438 | 523158 | 883573 | - |
2022-12-31 | 3438 | 523158 | 883573 | - |
OGEN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 7466 | 4785 |
2023-06-30 | 13163 | 11303 |
2023-03-31 | 131521 | 13073 |
2022-12-31 | 131521 | - |
OGEN
Price: $1.07
52 week price:
Earnings Per Share: -9.18 USD
P/E Ratio: -0.80
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 23200
Market Capitalization: 5.7 million